Rivastigmine
NDC 0378-9070, rivastigmine, patch, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-9070
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205622
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE4.6 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-9070-93 | 00378907093 | 30 POUCH in 1 CARTON (0378-9070-93) / 1 PATCH in 1 POUCH (0378-9070-16) / 24 h in 1 PATCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4ab335d1-19ee-4cd9-9776-8086645d19e4NADAC price for package 00378907093
GET /v1/drugs/nadac/00378907093
Use it
Look up 0378-9070 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-9070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.